Delcath Systems Inc. (NASDAQ:DCTH) dropped 5.4% during trading on Wednesday . The stock traded as low as $2.80 and last traded at $2.96, with a volume of 107,490 shares changing hands. The stock had previously closed at $3.13.

The company’s market capitalization is $4.58 million. The company’s 50 day moving average is $3.97 and its 200-day moving average is $4.77.

Delcath Systems (NASDAQ:DCTH) last announced its quarterly earnings results on Wednesday, May 4th. The medical device company reported ($0.08) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.19) by $0.11. Equities analysts forecast that Delcath Systems Inc. will post ($7.84) EPS for the current year.

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.